These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 18476960)
21. A morphological study of granulomas induced by subcutaneous injection of leuprorelin acetate. Watanabe T; Yamada N; Yoshida Y; Yamamoto O J Cutan Pathol; 2009 Dec; 36(12):1299-302. PubMed ID: 19469875 [TBL] [Abstract][Full Text] [Related]
24. Leflunomide in subacute cutaneous lupus erythematosus - two sides of a coin. Suess A; Sticherling M Int J Dermatol; 2008 Jan; 47(1):83-6. PubMed ID: 18173611 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus. von Pelchrzim R; Schmook T; Friedrich M; Worm M Int J Dermatol; 2006 Jan; 45(1):84-5. PubMed ID: 16426386 [No Abstract] [Full Text] [Related]
30. What should I know about Lupron Depot for treating prostate cancer? Johns Hopkins Med Lett Health After 50; 2012 Jan; 23(11):7. PubMed ID: 22396997 [No Abstract] [Full Text] [Related]
32. Leuprorelin: a leading role in advanced prostate cancer therapy. Persad R Hosp Med; 2003 Jun; 64(6):360-3. PubMed ID: 12833832 [TBL] [Abstract][Full Text] [Related]
33. Systemic allergic dermatitis caused by the solvent of Eligard. Ruiz-Hornillos J; Henríquez-Santana A; Moreno-Fernández A; González IG; Sánchez SR Contact Dermatitis; 2009 Dec; 61(6):355-6. PubMed ID: 20059500 [No Abstract] [Full Text] [Related]
34. Management of "refractory" skin disease in patients with lupus erythematosus. Callen JP Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):767-84. PubMed ID: 16150402 [TBL] [Abstract][Full Text] [Related]